Pacing-induced cardiomyopathy: pathophysiological insights through matrix metalloproteinases
Related Experiment Video
Updated: May 9, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Fozia Z Ahmed1, Rajdeep S Khattar, Amir M Zaidi
1Manchester Heart Centre, Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WL, UK, foziaahmed@doctors.org.uk.
Insights
Chronic right ventricular pacing can cause heart dysfunction. Matrix metalloproteinases (MMPs) are implicated in pacing-induced cardiomyopathy (PiCMP) development, suggesting new prevention strategies.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Pacing-induced ventricular dysfunction and cardiomyopathy (PiCMP) are known complications of chronic right ventricular pacing.
- Myocardial perfusion and sympathetic innervation changes contribute to pacing-induced heart disease, but other mechanisms are likely involved.
Purpose of the Study:
- To review the clinical epidemiology of pacing-induced ventricular dysfunction.
- To explore the role of matrix metalloproteinases (MMPs) in the development of PiCMP using insights from animal models.
- To discuss potential pacing strategies for preventing pacing-induced ventricular dysfunction.
Main Methods:
- Literature review of clinical epidemiology of pacing-induced ventricular dysfunction.
- Analysis of data from animal models to understand MMP expression and function in PiCMP.
- Exploration of preventative pacing strategies.
Main Results:
- Matrix metalloproteinases (MMPs) are key in extracellular matrix degradation and left ventricular remodeling in heart failure.
- While MMP roles in other cardiomyopathies are defined, their specific involvement in PiCMP is not well-reported.
- Animal models offer insights into how altered MMP expression and function contribute to PiCMP.
Conclusions:
- Matrix metalloproteinases (MMPs) are likely involved in the pathophysiology of pacing-induced cardiomyopathy (PiCMP).
- Further research into MMPs in PiCMP could lead to novel therapeutic and preventative strategies.
- Optimizing pacing strategies may mitigate the risk of developing pacing-induced ventricular dysfunction.
Abstract:
Pacing-induced ventricular dysfunction and pacing-induced cardiomyopathy (PiCMP) are recognized complications of chronic right ventricular pacing. Alterations in myocardial perfusion and sympathetic innervation contribute to the development of pacing-induced heart disease. However, it is unlikely that these are the only processes involved. Matrix metalloproteinases (MMPs) are proteolytic enzymes that degrade the collagenous extracellular matrix and play a central role in left ventricular remodelling during the development of heart failure. While the pathophysiological mechanisms and altered MMP expression that occur in chronic pressure overload, ischaemic and non-ischaemic dilated cardiomyopathy have been defined, those that occur in the clinical setting of pacing-induced ventricular dysfunction and PiCMP have not been reported. Here we review the clinical epidemiology of pacing-induced ventricular dysfunction and discuss how data derived from animal models provide insight into how changes in MMP expression and function contribute to the development of PiCMP. The review concludes by exploring pacing strategies that may be used to prevent pacing-induced ventricular dysfunction.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Myocarditis I: Introduction
Role of Matrix Metalloproteases in Degradation of ECM
A...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

